| Filed On | Filing |
|---|---|
| 05 Dec 2024 |
Form 4: Mehrotra Ravi, Director
Granted 50,000 Stock Option (Right to Buy) |
| 26 Nov 2024 |
Form 4: Nelson Jennifer Ann, Chief Scientific Officer
Granted 110,000 Stock Option (Right to Buy) |
| 15 Nov 2024 |
Form 4: Certel Kaan, Director
Granted 340,000 Stock Option (Right to Buy) |
| 04 Oct 2024 |
Form 4: Rosiello Robert L., Director
Granted 50,000 Stock Option (Right to Buy) |
| 21 Jun 2024 |
Form 4: Szela Mary T, Director
Granted 25,000 Stock Option (Right to Buy) |
| 21 Jun 2024 |
Form 4: Boehm Rainer J., Director
Granted 25,000 Stock Option (Right to Buy) |
| 21 Jun 2024 |
Form 4: Schade Christian S, Director
Granted 25,000 Stock Option (Right to Buy) |
| 21 Jun 2024 |
Form 4: Mendlein John, Director
Granted 25,000 Stock Option (Right to Buy) |
| 21 Jun 2024 |
Form 4: Levy Elliott M., Director
Granted 25,000 Stock Option (Right to Buy) |
| 21 Jun 2024 |
Form 4: Young Richard A, Director
Granted 25,000 Stock Option (Right to Buy) |
| 21 Jun 2024 |
Form 4: Werner Michelle C, Director
Granted 25,000 Stock Option (Right to Buy) |
| 21 Jun 2024 |
Form 4: Kender Richard N, Director
Granted 50,000 Stock Option (Right to Buy) |
| 31 May 2024 |
Form 4: Certel Kaan, Chief Business Officer
Granted 220,000 Stock Option (Right to Buy) |
| 09 Feb 2024 |
Form 4: McCauley Thomas, Chief Scientific Officer
Granted 200,000 Stock Option (Right to Buy) |
| 09 Feb 2024 |
Form 4: Karande Mahesh, Director
Granted 523,877 Stock Option (Right to Buy) |
| 09 Feb 2024 |
Form 4: Moore Yan, Chief Medical Officer
Granted 110,000 Stock Option (Right to Buy) |
| 09 Feb 2024 |
Form 4: Reed Joshua, Chief Financial Officer
Granted 110,000 Stock Option (Right to Buy) |
| 09 Feb 2024 |
Form 4: Schade Christian S, Director
Granted 512,848 Stock Option (Right to Buy) |
| 09 Feb 2024 |
Form 4: Zeng Ling, See Remarks
Granted 125,000 Stock Option (Right to Buy) |
| 29 Aug 2023 |
Form 4: Werner Michelle C, Director
Granted 36,713 Stock Option (Right to Buy) |
Loading...
